{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:02:31Z","timestamp":1777874551737,"version":"3.51.4"},"reference-count":61,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"4","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Taxane-induced peripheral neuropathy (TIPN) is a common, dose-limiting, and often irreversible toxicity that profoundly diminishes patients' long-term quality of life and compromises taxane treatment efficacy. This study aimed to identify and replicate plasma lipidomic biomarkers of TIPN and paclitaxel pharmacokinetics (PK).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      This retrospective analysis used data from a prospective cohort of female patients with early-stage breast cancer receiving once weekly paclitaxel. TIPN was assessed pretreatment and once weekly before each infusion using the European Organization for Research and Treatment of Cancer QLQ-CIPN20 sensory subscale (CIPN8). Paclitaxel PK parameters were estimated from blood samples collected within 10 minutes before the end of first infusion (C\n                      <jats:sub>max<\/jats:sub>\n                      ) and 16-24 hours later (T\n                      <jats:sub>c&gt;0.05<\/jats:sub>\n                      ). Plasma lipidomics were quantified using the end-of-infusion sample. Linear mixed-effects and linear regression models were used to identify lipids associated with TIPN severity and paclitaxel PK, respectively, with a prespecified false discovery rate of 0.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Among 36 patients, lower sphingomyelin (SM 40:1;3O, a random representative of nine correlated lipids), lower lysophosphatidylethanolamine (LPE O-22:1), higher ceramide (Cer 36:0;2O), and higher phosphatidylinositol (PI 34:2) were associated with greater sensory TIPN. Previously reported associations of phosphoethanolamines, triacylglycerols, and phosphatidylglycerols lipid classes with TIPN were not replicated. Reduced levels of seven correlated lipid species from the (lyso)phosphatidylethanolamine and (lyso)phosphatidylcholine classes were associated with higher paclitaxel C\n                      <jats:sub>max<\/jats:sub>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      End-of-first-infusion lipidomic profiles identified candidate biomarkers associated with TIPN severity and paclitaxel C\n                      <jats:sub>max<\/jats:sub>\n                      . Larger prospective studies are needed to validate these findings and inform the development of lipid-guided personalized treatment strategies that mitigate TIPN and improve long-term outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/po-25-01196","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:59:11Z","timestamp":1777579151000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Lipidomic Predictors of Paclitaxel-Induced Peripheral Neuropathy"],"prefix":"10.1200","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2842-3797","authenticated-orcid":true,"given":"Yaping","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-0958","authenticated-orcid":false,"given":"Ciao-sin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam","family":"Nguyen-Hoang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7388-8520","authenticated-orcid":true,"given":"Alla","family":"Karnovsky","sequence":"additional","affiliation":[{"name":"Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4771-5930","authenticated-orcid":true,"given":"N. Lynn","family":"Henry","sequence":"additional","affiliation":[{"name":"Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI"},{"name":"Department of Internal Medicine, Division of Hematology\/Oncology, University of Michigan Medical School, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0238-7774","authenticated-orcid":true,"given":"Kathleen A.","family":"Stringer","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0501-1035","authenticated-orcid":true,"given":"Daniel L.","family":"Hertz","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI"},{"name":"Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_9_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.09.020"},{"key":"e_1_3_9_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4202"},{"key":"e_1_3_9_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.3552"},{"key":"e_1_3_9_5_2","first-page":"1","article-title":"Global estimates of prevalence of chronic painful neuropathy among patients with chemotherapy-induced peripheral neuropathy: Systematic review and meta-analysis of data from 28 countries, 2000-24","author":"D\u2019Souza RS","year":"2025","unstructured":"D\u2019Souza RS, Saini C, Hussain N, et al: Global estimates of prevalence of chronic painful neuropathy among patients with chemotherapy-induced peripheral neuropathy: Systematic review and meta-analysis of data from 28 countries, 2000-24. Reg Anesth Pain Med 1-9, 2025","journal-title":"Reg Anesth Pain Med"},{"key":"e_1_3_9_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0000000000000684"},{"key":"e_1_3_9_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01399"},{"key":"e_1_3_9_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.4668"},{"key":"e_1_3_9_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0656"},{"key":"e_1_3_9_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-024-04677-1"},{"key":"e_1_3_9_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw290"},{"key":"e_1_3_9_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13982"},{"key":"e_1_3_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114024"},{"key":"e_1_3_9_14_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.7062"},{"key":"e_1_3_9_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14192"},{"key":"e_1_3_9_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4862-3"},{"key":"e_1_3_9_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-024-04680-6"},{"key":"e_1_3_9_18_2","article-title":"Quantitation of plasma proteins to predict taxane-induced peripheral neuropathy","author":"Nguyen-Hoang N","unstructured":"Nguyen-Hoang N, Liu Y, Henry NL, et al: Quantitation of plasma proteins to predict taxane-induced peripheral neuropathy. JCO Precis Oncol 10.1200\/PO-24-00380","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_9_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104739"},{"key":"e_1_3_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2025.04.006"},{"key":"e_1_3_9_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1337150"},{"key":"e_1_3_9_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051149"},{"key":"e_1_3_9_23_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00208"},{"key":"e_1_3_9_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2022.04.006"},{"key":"e_1_3_9_25_2","article-title":"Plasma lipidomic profiling identifies elevated triglycerides as potential risk factor in chemotherapy-induced peripheral neuropathy","author":"Yeung N","unstructured":"Yeung N, Li T, Lin HM, et al: Plasma lipidomic profiling identifies elevated triglycerides as potential risk factor in chemotherapy-induced peripheral neuropathy. JCO Precis Oncol 10.1200\/PO.23.00690","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_9_26_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.15-272567"},{"key":"e_1_3_9_27_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.569574"},{"key":"e_1_3_9_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.02.012"},{"key":"e_1_3_9_29_2","doi-asserted-by":"crossref","unstructured":"Kraff S Lindauer A Joerger M et al: Excel-based tool for pharmacokinetically guided dose adjustment of paclitaxel. Ther Drug Monit 37:725-732 2015","DOI":"10.1097\/FTD.0000000000000206"},{"key":"e_1_3_9_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2016.08.007"},{"key":"e_1_3_9_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2551"},{"key":"e_1_3_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100138"},{"key":"e_1_3_9_33_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.S120001025"},{"key":"e_1_3_9_34_2","volume-title":"R A Language and Environment for Statistical Computing","author":"Team RC","year":"2025","unstructured":"Team RC: R A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2025"},{"key":"e_1_3_9_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2900"},{"key":"e_1_3_9_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx012"},{"key":"e_1_3_9_37_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.1c05430"},{"key":"e_1_3_9_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.64010424.x"},{"key":"e_1_3_9_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2017.1390580"},{"key":"e_1_3_9_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2015.03.012"},{"key":"e_1_3_9_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2007.12.041"},{"key":"e_1_3_9_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14178"},{"key":"e_1_3_9_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66815-y"},{"key":"e_1_3_9_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.12003"},{"key":"e_1_3_9_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0563-z"},{"key":"e_1_3_9_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2006.10.006"},{"key":"e_1_3_9_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1868"},{"key":"e_1_3_9_48_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi061657l"},{"key":"e_1_3_9_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-018-1365-5"},{"key":"e_1_3_9_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.296"},{"key":"e_1_3_9_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2015.03.013"},{"key":"e_1_3_9_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02534280"},{"key":"e_1_3_9_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)38050-0"},{"key":"e_1_3_9_54_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102548"},{"key":"e_1_3_9_55_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401277R"},{"key":"e_1_3_9_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2025.104963"},{"key":"e_1_3_9_57_2","doi-asserted-by":"publisher","unstructured":"Loprinzi CL Harlos B Staff N et al: Fingolimod for treatment and or prevention of chemotherapy-induced peripheral neuropathy in humans? medRxiv 10.1101\/2022.09.08.22279733","DOI":"10.1101\/2022.09.08.22279733"},{"key":"e_1_3_9_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15244"},{"key":"e_1_3_9_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18716-5"},{"key":"e_1_3_9_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002840"},{"key":"e_1_3_9_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08074-x"},{"key":"e_1_3_9_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2011.00351.x"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-25-01196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:59:15Z","timestamp":1777579155000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-25-01196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1200\/PO-25-01196"],"URL":"https:\/\/doi.org\/10.1200\/po-25-01196","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2501196"}}